ATYR aTYR PHARMA INCcompanySEC Filings & Insider Trading Activity 2026
Latest aTYR PHARMA INC (ATYR) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on March 5, 2026, a 10-Q quarterly report filed on May 15, 2026, an 8-K current report filed on July 31, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for aTYR PHARMA INC (ATYR) (SEC CIK 1339970), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on aTYR PHARMA INC
Ask AI about ATYR filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting ATYR positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on ATYR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of aTYR PHARMA INC (ATYR) 8-K current reports disclosing material events.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Jul 31, 2026 | - | - | - |
8-K | Jun 8, 2026 | - | - | |
8-K | Jun 1, 2026 | - | - | |
10-Q | May 15, 2026 | Mar 31, 2026 | - | |
8-K | May 15, 2026 | - | - | |
8-K | May 11, 2026 | - | - | |
8-K | Mar 5, 2026 | - | Analysis | - |
10-K | Mar 5, 2026 | Dec 31, 2025 | - | |
8-K | Dec 5, 2025 | - | - | |
10-Q | Nov 6, 2025 | Sep 30, 2025 | - | |
10-Q | Aug 7, 2025 | Jun 30, 2025 | - | |
10-Q | May 7, 2025 | Mar 31, 2025 | - | |
10-K | Mar 13, 2025 | Dec 31, 2024 | - | |
10-Q | Nov 7, 2024 | Sep 30, 2024 | - | |
SC 13G | Oct 15, 2024 | - | - | |
10-Q | Aug 13, 2024 | Jun 30, 2024 | - | |
10-Q | May 2, 2024 | Mar 31, 2024 | - | |
10-K | Mar 14, 2024 | Dec 31, 2023 | - | |
SC 13G | Jan 2, 2024 | - | - | |
10-Q | Nov 9, 2023 | Sep 30, 2023 | - | |
10-Q | Aug 9, 2023 | Jun 30, 2023 | - | |
10-Q | May 9, 2023 | Mar 31, 2023 | - | |
10-K | Mar 14, 2023 | Dec 31, 2022 | - | |
SC 13G | Feb 22, 2023 | - | - | |
10-Q | Nov 14, 2022 | Sep 30, 2022 | - |
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate ATYR share value held by 13F filers tracked by SignalX, by quarter.
- Two Sigma Investments+690.1K (+152%)
- Bank of America Corp+176.9K (+140%)
- State Street Corp+29.6K (+2%)
- Northern Trust+8.9K (+1%)
- FMR LLC (Fidelity)+8.8K (+0%)
- AQR Capital Management273.8K (-36%)
- Citadel Advisors LLC177.6K (-47%)
- Morgan Stanley177.5K (-13%)
- BlackRock105.8K (-2%)
- Wells Fargo & Co70.2K (-60%)
- Millennium Management+1.64M
- Renaissance Technologies LLC+40.5K
- Prudential Financial+14.7K
- Vanguard Group Inc−4.96M
- JPMorgan Chase & Co−110.4K
- Invesco Ltd−46.2K
Source: 13F-HR filings on SEC EDGAR (aggregated from 121 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest ATYR SEC filings in 2026?
aTYR PHARMA INC (ATYR) has filed a 10-K annual report on March 5, 2026, a 10-Q quarterly report on May 15, 2026, an 8-K current report on July 31, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did ATYR file its most recent 10-K annual report?
aTYR PHARMA INC (ATYR) filed its most recent 10-K annual report on March 5, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view ATYR 10-Q quarterly reports?
aTYR PHARMA INC (ATYR)'s most recent 10-Q quarterly report was filed on May 15, 2026. SignalX displays every ATYR 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has ATYR filed recently?
aTYR PHARMA INC (ATYR)'s most recent 8-K was filed on July 31, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find ATYR insider trading activity (Form 4)?
SignalX aggregates every ATYR Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does ATYR file with the SEC?
aTYR PHARMA INC (ATYR) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new ATYR filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for aTYR PHARMA INC (ATYR).
What is ATYR's SEC CIK number?
aTYR PHARMA INC (ATYR)'s SEC CIK (Central Index Key) number is 1339970. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1339970 to look up all ATYR filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Stay on top of aTYR PHARMA INC SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 76+ filings.